ArticleCell death & disease2024

Metabolic remodeling by the PD-L1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastoma.

Xueou Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.